November 18, 2016
November 18, 2016 —
An international team of computer scientists has for the first time developed a method to find antibiotics hidden in huge but still unexplored mass spectrometry datasets. They detailed their new method, called DEREPLICATOR, in the Oct. 31 issue of Nature Chemical Biology.
April 13, 2012
April 13, 2012 —
Scott M. Lippman, MD, chair of Thoracic/Head and Neck Medical Oncology at The University of Texas (UT) MD Anderson Cancer Center, has accepted the position of director of Moores Cancer Center at the University of California, San Diego, beginning May 1, 2012.
December 18, 2018
December 18, 2018 —
UC San Diego’s Chancellor Pradeep K. Khosla and Professor Susan Taylor were named fellows of the National Academy of Inventors. They are part of the NAI’s 2018 cohort of 148 new fellows who have demonstrated a prolific spirit of innovation.
September 6, 2022
September 6, 2022 —
Noted businessman and philanthropist T. Denny Sanford has committed $150 million in new funding to expand and, in some ways, quite literally launch stem cell research and regenerative medicine at University of California San Diego into new spaces and endeavors.
September 17, 2015
September 17, 2015 —
More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid. In fact, patients with Down syndrome develop the abnormal protein at twice the rate. Results of a pilot…
July 29, 2024
July 29, 2024 —
UC San Diego was enlisted by the White House to help host the first meeting of an international coalition aimed at addressing the growing crisis of drug shortages around the world.
August 2, 2021
August 2, 2021 —
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
January 28, 2019
January 28, 2019 —
A team of researchers led by the University of California San Diego has identified a genetic pathway that causes some individuals to develop an abnormal heart rhythm, or arrhythmia, after experiencing a heart attack. They have also identified a drug candidate that can block this pathway.
September 27, 2012
September 27, 2012 —
…This precursor molecule could provide a new target for drugs designed to treat atherosclerosis.
April 21, 2017
April 21, 2017 —
The Amazonian Center of Excellence for Malaria Research, headed by Joseph Vinetz, MD, professor of medicine and tropical disease specialist at University of California San Diego School of Medicine, will receive up to approximately $8.3 million over seven years from the National Institute of Allergy and Infectious Diseases (NIAID), part…